The information on this site is intended only for institutional investors and consultants to separately managed account investors. It is not intended for use by or distribution to members of the general public. The information on this site is for informational purposes and does not constitute an offer to sell or a solicitation of an offer to buy any security which may be referenced herein. The information on this site is published without regard to the investment objective, financial situation or specific needs of any particular investor. The information on this site is intended for U.S. residents only and is not intended for investors in any jurisdiction in which distribution or purchase is not authorized.

Please confirm that you have read and agree to the terms above.

Thank you for your interest in Victory Capital Management. To download this document, please complete the registration form below. You will only need to complete this form one time to access site content.

  • Victory Capital may use my email to send out periodic news, announcements, and product information.

*All fields are required

RS Investments

RS Investments Logo


Daniel Lang

Daniel Lang, M.D.

Chief Investment Officer

Daniel Lang is Chief Investment Officer of the RS Value team. RS Investments was acquired by Victory Capital in July 2016 and is a Victory Capital investment franchise.

Mr. Lang began his investment career in 2001. Prior to joining RS Investments in 2009, he was a portfolio manager at Farallon Capital Management covering the global biotechnology, medical device, pharmaceutical, and health care services industries. Previously, he was a senior associate at venture capital firm Brilleon Capital US and the co-founder and CFO of Sapient Medical Group. Mr. Lang’s business and investment experience was preceded by a distinguished career practicing medicine. He was a fellow in cardiology and a post-doctoral research fellow at the University of California, San Francisco. Additionally, he was board certified in internal medicine and served as a chief medical resident at Mount Sinai Hospital in New York.

Mr. Lang holds a B.A. in chemistry from Cornell University and an M.D. from Cornell University Medical College.